LGG-38. Dose-dependent seizure control for an NF1 patient treated via MEK-inhibition for optic pathway glioma

Authors: Evan Cantor, Ashley Meyer, Andrea Ogle, Margaret Shatara, Andrew Cluster, Mohamed S Abdelbaki, Stephanie Morris, Judith Weisenberg, Nicole M Brossier

Published: 2022-06-03

DOI: 10.1093/neuonc/noac079.350

Source: Full article


Abstract

Abstract